After years of rigorous R&D, Véto-pharma has obtained federal registration for a unique and innovative amitraz gel formulation that’s specially designed to address the needs of commercial beekeepers. This 7-day-flash treatment is temperature independent and comes in a tailor-made package to reduce labor costs. Its distinctive versatility allows for use in between honey flows and eliminates the need for a withdrawal period while delivering accurate and controlled dosages.

Amiflex® possesses optimal efficacy and comes in a fast and convenient ‘ready-to-use’ formulation that’s safe for colonies and affordable for beekeepers.

Optimal efficacy:
Amiflex is a 7-day treatment that can be used 1-4 times a year. The new gel formulation provides a faster release of amitraz than plastic strip applications, achieving 94% efficacy on the 3rd day of application and 100% on the 7th day in broodless colonies. Amiflex also ensures a quick knock-down of varroa mites in the presence of brood with one or two applications, according to the infestation rate.

Ready to use and guaranteed safety:
Amiflex was designed to be non-labor intensive, decreasing preparation and application time, while guaranteeing a high level of safety for honeybees and minimizing the beekeeper’s exposure to the product.

Availability:
Amiflex has been approved by the EPA and will be available soon to beekeepers in accordance with local state registrations. You can learn more about Amiflex by visiting the Véto-pharma website at:
www.veto-pharma.com/products/amiflex

Climate change, growing drought, overuse of pesticides, deficient nutrition and the effects of pathogens (where varroa mites play a major role) negatively impact the survival of these pollinators. The lack of products available to help beekeepers adapt their strategies for varroa control limits options and makes things progressively more challenging. It is therefore essential to be able to rely on highly effective and versatile products that can be adapted to the conditions of the hive throughout the beekeeping year.

At Véto-pharma, we understand that the health and survival of honeybees are major issues that have exceeded our borders for several decades. We know that these sentinels of our environment are responsible for the production of around 30% of the world’s consumable food and many are worried about their future.

Founded in 1982, Véto-pharma is a veterinary pharmaceutical laboratory that has spent nearly 3 decades exclusively dedicating its expertise and know-how to offering innovative solutions in the field of honeybee health.

Véto-pharma has become a world leader in honeybee health, working daily to safeguard the future of the beekeeping industry by developing and producing a range of medicines and nonmedicinal products in France that are recognized worldwide for their high quality and added value.